Edwards Lifesciences Corp Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Edwards Lifesciences Corp's estimated annual revenue is currently $5.1B per year.(i)
  • Edwards Lifesciences Corp's estimated revenue per employee is $320,065
  • Edwards Lifesciences Corp's current valuation is $73.8B. (January 2022)

Employee Data

  • Edwards Lifesciences Corp has 15903 Employees.(i)
  • Edwards Lifesciences Corp grew their employee count by 7% last year.

Edwards Lifesciences Corp's People

NameTitleEmail/Phone
1
Chief Enterprise ArchitectReveal Email/Phone
2
Chief Scientific Officer & Corporate VPReveal Email/Phone
3
TMTT VP and Japan Business Unit HeadReveal Email/Phone
4
VPReveal Email/Phone
5
Executive Assistant to the VP, TMTT Global Marketing and the VP, StrategyReveal Email/Phone
6
Area VP, THVReveal Email/Phone
7
Sr. VP, Japan Asia Pacific Region FinanceReveal Email/Phone
8
Chief Operating OfficerReveal Email/Phone
9
Chief Scientific Officer & Corporate VPReveal Email/Phone
10
VPReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$68.5M273N/AN/AN/A
Add Company

What Is Edwards Lifesciences Corp?

Edwards Lifesciences Corp provides a comprehensive line of products and services to treat late-stage cardiovascular disease. The Company's sales are categorized in four main product areas: cardiac surgery, critical care, vascular, and perfusion products and services. Edwards Lifesciences, which is headquartered in Irvine, California, supplies its products and services to customers in more than 80 countries, both through direct sales and distributor relationships.

keywords:N/A

N/A

Total Funding

15903

Number of Employees

$5.1B

Revenue (est)

7%

Employee Growth %

$73.8B

Valuation

N/A

Accelerator

Edwards Lifesciences Corp News

2022-04-20 - Edwards Lifesciences Corp. stock underperforms Thursday when compared to competitors

Shares of Edwards Lifesciences Corp. EW, -0.03% sank 0.03% to $109.77 Thursday, on what proved to be an all-around positive trading session for...

2022-04-19 - Edwards Lifesciences Corp. stock underperforms Wednesday when compared to competitors

Shares of Edwards Lifesciences Corp. EW, -1.17% slipped 5.56% to $109.80 Wednesday, on what proved to be an all-around favorable trading...

2022-04-17 - Edwards Lifesciences: Q1 Earnings Snapshot

(AP) _ Edwards Lifesciences Corp. (EW) on Tuesday reported first-quarter net income of $373.6 million. On a per-share basis, the Irvine,...

2021-10-28 - Edwards Lifesciences reports mixed Q3 financial results

Edwards Lifesciences (NYSE: EW) reported third-quarter financial results that exceeded Wall Street’s expectations on profits but narrowly missed on sales. The Irvine, California–based cardio device company yesterday evening reported earnings of $340.1 million (or 54¢ per share) off sales of $1. ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6131.2M162203%N/A
#2
$5100.8M25127N/AN/A
#3
$5914.2M285230%N/A
#4
$3420M318333%N/A
#5
$16215.7M46146N/AN/A